Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 1,750 shares at $105.47 ($185K) on 2026-04-20, disclosed to the SEC on 2026-04-21.
Seasonal sale ($185k) by Chief Financial Officer — this insider has traded PTGX in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2026-01-27 | $3.8M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |
| PTGX | SELL | 2025-04-23 | $81K | — | Filing → |